A WHO and UNAIDS meeting discussed the issues of gender and age, as well as race, in HIV trials. Macklin is quoted: “We have identified measures aimed at rectifying the injustice stemming from the frequent exclusion or low participation of women and adolescents in HIV vaccine clinical trials. Clinical trial enrolment needs to be more inclusive, so the benefits of research are more fairly distributed.”
Labels: clinical trials, gender, HIV, race, UNAIDS, vaccines, vulnerable subject populations, WHO